Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

Contributed by: PR Newswire

Tags

Valinor-Grünenthal

More Like This

PR Newswire associated0

Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

GlobeNewswire associated0

Olon Continues its Growth Path and Announces a New Acquisition

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe

PR Newswire associated0

Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

PR Newswire associated0

Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Business Wire logo

Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca

PR Newswire associated0

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk

ZINZINO AB (PUBL.): Zinzino acquires Valentus Global to increase distribution power in Europe